Literature DB >> 19395696

Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort.

Xiaomei Ma1, Unhee Lim, Yikyung Park, Susan T Mayne, Rong Wang, Patricia Hartge, Albert R Hollenbeck, Arthur Schatzkin.   

Abstract

The etiology of myelodysplastic syndromes (MDS) is not well understood. The authors examined the relations of obesity and lifestyle factors to MDS in a cohort of 471,799 persons aged 50-71 years who were recruited into the National Institutes of Health-AARP Diet and Health Study, a large US prospective study, in 1995-1996. Incident MDS was diagnosed in 193 persons during 2001-2003. A significant positive association was observed between body mass index (BMI; weight (kg)/height (m)(2)) at baseline and MDS. Compared with persons with a BMI less than 25.0, the hazard ratios for persons with BMIs of 25.0-<30.0 and >or=30.0 were 1.15 (95% confidence interval (CI): 0.81, 1.64) and 2.18 (95% CI: 1.51, 3.17; P for trend < 0.001), respectively. The association was not affected by physical activity, cigarette smoking, or alcohol intake. As reported in previous studies, the risk of MDS was elevated among former smokers (hazard ratio = 1.68, 95% CI: 1.17, 2.41) and current smokers (hazard ratio = 3.17, 95% CI: 2.02, 4.98) as compared with never smokers. Physical activity, alcohol consumption, meat intake, and fruit and vegetable intake did not appear to significantly influence the risk of MDS in this analysis. This prospective investigation of MDS implicates both obesity and smoking as modifiable risk factors.

Entities:  

Mesh:

Year:  2009        PMID: 19395696      PMCID: PMC2727203          DOI: 10.1093/aje/kwp074

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  28 in total

1.  Report of an international working group to standardize response criteria for myelodysplastic syndromes.

Authors:  B D Cheson; J M Bennett; H Kantarjian; A Pinto; C A Schiffer; S D Nimer; B Löwenberg; M Beran; T M de Witte; R M Stone; M Mittelman; G F Sanz; P W Wijermans; S Gore; P L Greenberg
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

Review 2.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms.

Authors:  Eugenia E Calle; Rudolf Kaaks
Journal:  Nat Rev Cancer       Date:  2004-08       Impact factor: 60.716

3.  World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

Authors:  N L Harris; E S Jaffe; J Diebold; G Flandrin; H K Muller-Hermelink; J Vardiman; T A Lister; C D Bloomfield
Journal:  J Clin Oncol       Date:  1999-12       Impact factor: 44.544

4.  Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study.

Authors:  A Schatzkin; A F Subar; F E Thompson; L C Harlan; J Tangrea; A R Hollenbeck; P E Hurwitz; L Coyle; N Schussler; D S Michaud; L S Freedman; C C Brown; D Midthune; V Kipnis
Journal:  Am J Epidemiol       Date:  2001-12-15       Impact factor: 4.897

5.  Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France.

Authors:  C Nisse; J M Haguenoer; B Grandbastien; C Preudhomme; B Fontaine; J M Brillet; R Lejeune; P Fenaux
Journal:  Br J Haematol       Date:  2001-03       Impact factor: 6.998

6.  Risk factors for myelodysplastic syndromes: a case-control study in Greece.

Authors:  Maria Dalamaga; Eleni Petridou; Francis E Cook; Dimitrios Trichopoulos
Journal:  Cancer Causes Control       Date:  2002-09       Impact factor: 2.506

Review 7.  The World Health Organization (WHO) classification of the myeloid neoplasms.

Authors:  James W Vardiman; Nancy Lee Harris; Richard D Brunning
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

8.  Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.

Authors:  Dana E Rollison; Nadia Howlader; Martyn T Smith; Sara S Strom; William D Merritt; Lynn A Ries; Brenda K Edwards; Alan F List
Journal:  Blood       Date:  2008-04-28       Impact factor: 22.113

9.  Association of obesity and cancer risk in Canada.

Authors:  Sai Yi Pan; Kenneth C Johnson; Anne-Marie Ugnat; Shi Wu Wen; Yang Mao
Journal:  Am J Epidemiol       Date:  2004-02-01       Impact factor: 4.897

Review 10.  Leptin in the regulation of immunity, inflammation, and hematopoiesis.

Authors:  G Fantuzzi; R Faggioni
Journal:  J Leukoc Biol       Date:  2000-10       Impact factor: 4.962

View more
  25 in total

1.  Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors.

Authors:  Stefani Parmentier; Johannes Schetelig; Kerstin Lorenz; Michael Kramer; Robin Ireland; Ulrich Schuler; Rainer Ordemann; Gabi Rall; Markus Schaich; Martin Bornhäuser; Gerhard Ehninger; Frank Kroschinsky
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

2.  Impact of tobacco usage on disease outcome in myelodysplastic syndromes.

Authors:  Asmita Mishra; Dana E Rollison; Thomas H Brandon; Najla H Al Ali; Maria Corrales-Yepez; Eric Padron; Pearlie K Epling-Burnette; Jeffrey E Lancet; Alan F List; Rami S Komrokji
Journal:  Leuk Res       Date:  2015-04-07       Impact factor: 3.156

Review 3.  Epidemiology of myelodysplastic syndromes.

Authors:  Xiaomei Ma
Journal:  Am J Med       Date:  2012-07       Impact factor: 4.965

4.  Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.

Authors:  Jenny N Poynter; Michaela Richardson; Michelle Roesler; Cindy K Blair; Betsy Hirsch; Phuong Nguyen; Adina Cioc; James R Cerhan; Erica Warlick
Journal:  Int J Cancer       Date:  2016-09-24       Impact factor: 7.396

5.  Does being overweight contribute to longer survival rates in myelodysplastic syndrome?

Authors:  Eric Solary; Michaela Fontenay
Journal:  Haematologica       Date:  2018-04       Impact factor: 9.941

6.  Obesity and neoplasms of lymphohematopoietic cells.

Authors:  Marshall A Lichtman
Journal:  Blood Adv       Date:  2016-11-22

7.  Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes.

Authors:  Jenny N Poynter; Michaela Richardson; Cindy K Blair; Michelle A Roesler; Betsy A Hirsch; Phuong Nguyen; Adina Cioc; Erica Warlick; James R Cerhan; Julie A Ross
Journal:  Cancer Epidemiol       Date:  2015-12-22       Impact factor: 2.984

8.  Alcohol consumption and risk of myelodysplastic syndromes: A meta-analysis of epidemiological studies.

Authors:  Jie Jin; Mengxia Yu; Chao Hu; Li Ye; Lili Xie; Feifei Chen; Zhengping Zhuang; Hongyan Tong
Journal:  Mol Clin Oncol       Date:  2014-08-07

9.  Alcohol use is not a significant contributor to myelodysplastic syndromes.

Authors:  Elizabeth A Duffy; Phuong L Nguyen; Adina Cioc; Erica Warlick; Michelle A Roesler; Jenny N Poynter
Journal:  Cancer Causes Control       Date:  2020-04-13       Impact factor: 2.506

Review 10.  [Myelodysplastic syndrome, acute leukemia and stem cell transplantation].

Authors:  M Schmalzing; M Aringer; M Bornhäuser; J Atta
Journal:  Z Rheumatol       Date:  2017-10       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.